1.16 USD
↘ 0.09 (7.20%)AT CLOSE (11:59 AM EDT)
Enlivex Ltd. Ordinary Shares
ENLVNASDAQ • USD
1.18
↗ 0.02 (1.81%)
POST MARKET (AS OF 06:57 PM EDT)
Post Market
AS OF 06:57 PM EDT
1.18
↗ 0.02 (1.81%)
Market: OPEN
ENLV is currently priced at $1.18. The technical outlook is "Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest ENLV is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Sep 3, 2026.
Open?$1.25
High?$1.28
Low?$1.13
Prev. Close?$1.25
Volume?294.0K
Avg. Volume?405.0K
VWAP?$1.21
Rel. Volume?0.73x
Bid / Ask
Bid?$0.96 × 100
Ask?$1.40 × 100
Spread?$0.44
Midpoint?$1.18
Valuation & Ratios
Market Cap?21.9M
Shares Out?17.5M
Float?32.2M
Float %?13.3%
P/E Ratio?N/A
P/B Ratio?0.62
EPS?-$0.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?80
Piotroski F-Score?0/9Weak
Altman Z-Score?6.47Safe
Confidence?40%Low
Short InterestLow
Short % of Float?0.32%Low
Short Interest?104.2K
Days to Cover?1.0
Free Float32.2M
Avg Daily Volume317.0K
Settlement Date2026-08-14
Financial Health
Current Ratio?8.72Strong
Quick Ratio?8.72Strong
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.62CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-23.7%WEAK▾
S&P7
ROA?-20.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$16.2M
Fundamentals ratios updated end of day